Patent Assignment
Reel/Frame 019773/0487
Merger and Change of Name
Recorded: 2007-08-30
Pages: 7
Assignor
REXAHN CORPORATION
Executed: 2005-09-29
Assignee
REXAHN PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DR., ROCKVILLE, MARYLAND, 20850
Covered Properties
(2)
Use of Antisense Oligonucleotides to Inhibit the Expression of Human Akt-1
Antisense Oligonucleotides That Inhibit Expression of Hif-1
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 18, 2006
From: YOON, HEEJEONG; MAO, LINGJUN; LEE, YOUNG BOK; AHN, CHANG HO
To: REXAHN CORPORATION
Reel/Frame 018205/0001 →
Change of Address of Assignee
Aug 18, 2006
From: YOON, HEEJEONG; MAO, LINGJUN; LEE, YOUNG BOK; AHN, CHANG HO
To: REXAHN CORPORATION
Reel/Frame 018206/0668 →
Change of Name
Nov 4, 2021
From: REXAHN PHARMACEUTICALS, INC.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 058032/0161 →